In addition, extracellular HMGB1 is involved in the pathogenesis of autoimmune diseases, as evidenced by the presence of anti-HMGB1 autoantibodies in sera from RA and drug-induced SLE patients (Wittemann et al., 1990; Ayer et al., 1994). Here, HMGB1 is linked to autoimmune disease.